Cargando…

Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial

OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEA...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamson, Philip D, Hunter, Amanda, Williams, Michelle C, Shah, Anoop S V, McAllister, David A, Pawade, Tania A, Dweck, Marc R, Mills, Nicholas L, Berry, Colin, Boon, Nicholas A, Clark, Elizabeth, Flather, Marcus, Forbes, John, McLean, Scott, Roditi, Giles, van Beek, Edwin J R, Timmis, Adam D, Newby, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861384/
https://www.ncbi.nlm.nih.gov/pubmed/28844992
http://dx.doi.org/10.1136/heartjnl-2017-311508
_version_ 1783308081698963456
author Adamson, Philip D
Hunter, Amanda
Williams, Michelle C
Shah, Anoop S V
McAllister, David A
Pawade, Tania A
Dweck, Marc R
Mills, Nicholas L
Berry, Colin
Boon, Nicholas A
Clark, Elizabeth
Flather, Marcus
Forbes, John
McLean, Scott
Roditi, Giles
van Beek, Edwin J R
Timmis, Adam D
Newby, David E
author_facet Adamson, Philip D
Hunter, Amanda
Williams, Michelle C
Shah, Anoop S V
McAllister, David A
Pawade, Tania A
Dweck, Marc R
Mills, Nicholas L
Berry, Colin
Boon, Nicholas A
Clark, Elizabeth
Flather, Marcus
Forbes, John
McLean, Scott
Roditi, Giles
van Beek, Edwin J R
Timmis, Adam D
Newby, David E
author_sort Adamson, Philip D
collection PubMed
description OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI). RESULTS: In 3770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk (RR) 2.22 (95% CI 1.91 to 2.60), p<0.001) than those with non-anginal symptoms (RR 1.30 (1.11 to 1.53), p=0.002; p(interaction) <0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p<0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379). CONCLUSIONS: NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT01149590;post results.
format Online
Article
Text
id pubmed-5861384
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58613842018-03-22 Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial Adamson, Philip D Hunter, Amanda Williams, Michelle C Shah, Anoop S V McAllister, David A Pawade, Tania A Dweck, Marc R Mills, Nicholas L Berry, Colin Boon, Nicholas A Clark, Elizabeth Flather, Marcus Forbes, John McLean, Scott Roditi, Giles van Beek, Edwin J R Timmis, Adam D Newby, David E Heart Coronary Artery Disease OBJECTIVES: To evaluate the diagnostic and prognostic benefits of CT coronary angiography (CTCA) using the 2016 National Institute for Health and Care Excellence (NICE) guidelines for the assessment of suspected stable angina. METHODS: Post hoc analysis of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial of 4146 participants with suspected angina randomised to CTCA. Patients were dichotomised into NICE guideline-defined possible angina and non-anginal presentations. Primary (diagnostic) endpoint was diagnostic certainty of angina at 6 weeks and prognostic endpoint comprised fatal and non-fatal myocardial infarction (MI). RESULTS: In 3770 eligible participants, CTCA increased diagnostic certainty more in those with possible angina (relative risk (RR) 2.22 (95% CI 1.91 to 2.60), p<0.001) than those with non-anginal symptoms (RR 1.30 (1.11 to 1.53), p=0.002; p(interaction) <0.001). In the possible angina cohort, CTCA did not change rates of invasive angiography (p=0.481) but markedly reduced rates of normal coronary angiography (HR 0.32 (0.19 to 0.52), p<0.001). In the non-anginal cohort, rates of invasive angiography increased (HR 1.82 (1.13 to 2.92), p=0.014) without reducing rates of normal coronary angiography (HR 0.78 (0.30 to 2.05), p=0.622). At 3.2 years of follow-up, fatal or non-fatal MI was reduced in patients with possible angina (3.2% to 1.9%%; HR 0.58 (0.34 to 0.99), p=0.045) but not in those with non-anginal symptoms (HR 0.65 (0.25 to 1.69), p=0.379). CONCLUSIONS: NICE-guided patient selection maximises the benefits of CTCA on diagnostic certainty, use of invasive coronary angiography and reductions in fatal and non-fatal myocardial infarction. Patients with non-anginal chest pain derive minimal benefit from CTCA and increase the rates of invasive investigation. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT01149590;post results. BMJ Publishing Group 2018-02 2017-08-27 /pmc/articles/PMC5861384/ /pubmed/28844992 http://dx.doi.org/10.1136/heartjnl-2017-311508 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Coronary Artery Disease
Adamson, Philip D
Hunter, Amanda
Williams, Michelle C
Shah, Anoop S V
McAllister, David A
Pawade, Tania A
Dweck, Marc R
Mills, Nicholas L
Berry, Colin
Boon, Nicholas A
Clark, Elizabeth
Flather, Marcus
Forbes, John
McLean, Scott
Roditi, Giles
van Beek, Edwin J R
Timmis, Adam D
Newby, David E
Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title_full Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title_fullStr Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title_full_unstemmed Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title_short Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
title_sort diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 national institute for health and care excellence guidance within a randomised trial
topic Coronary Artery Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861384/
https://www.ncbi.nlm.nih.gov/pubmed/28844992
http://dx.doi.org/10.1136/heartjnl-2017-311508
work_keys_str_mv AT adamsonphilipd diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT hunteramanda diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT williamsmichellec diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT shahanoopsv diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT mcallisterdavida diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT pawadetaniaa diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT dweckmarcr diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT millsnicholasl diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT berrycolin diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT boonnicholasa diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT clarkelizabeth diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT flathermarcus diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT forbesjohn diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT mcleanscott diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT roditigiles diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT vanbeekedwinjr diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT timmisadamd diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial
AT newbydavide diagnosticandprognosticbenefitsofcomputedtomographycoronaryangiographyusingthe2016nationalinstituteforhealthandcareexcellenceguidancewithinarandomisedtrial